Alana Arnold

691 total citations
13 papers, 441 citations indexed

About

Alana Arnold is a scholar working on Infectious Diseases, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Alana Arnold has authored 13 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Pharmacology and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Alana Arnold's work include Antimicrobial Resistance in Staphylococcus (3 papers), Pharmaceutical studies and practices (3 papers) and Computational Drug Discovery Methods (2 papers). Alana Arnold is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (3 papers), Pharmaceutical studies and practices (3 papers) and Computational Drug Discovery Methods (2 papers). Alana Arnold collaborates with scholars based in United States, Vietnam and Canada. Alana Arnold's co-authors include Ben Y. Reis, Shannon Manzi, Aurel Cami, Anahita F. Dioun, Stuart E. Turvey, Beth Cronin, Thomas Moniz, Peter Forbes, Edward J. OʼRourke and Anne Hansen and has published in prestigious journals such as PLoS ONE, Science Translational Medicine and The Journal of Pediatrics.

In The Last Decade

Alana Arnold

13 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alana Arnold United States 11 136 117 99 91 68 13 441
Alphienes Stanley Xavier India 12 27 0.2× 71 0.6× 141 1.4× 120 1.3× 51 0.8× 24 518
George Adjei Ghana 19 70 0.5× 39 0.3× 85 0.9× 55 0.6× 10 0.1× 55 914
Lionel Van Holle Belgium 11 73 0.5× 83 0.7× 69 0.7× 19 0.2× 215 3.2× 17 385
Fatai A. Fehintola Nigeria 16 83 0.6× 24 0.2× 101 1.0× 37 0.4× 35 0.5× 66 811
Maxwell Chirehwa South Africa 17 15 0.1× 144 1.2× 396 4.0× 66 0.7× 10 0.1× 39 675
Patricia Lizak United States 15 24 0.2× 125 1.1× 296 3.0× 69 0.8× 8 0.1× 23 637
Eliford Ngaimisi Tanzania 16 27 0.2× 21 0.2× 333 3.4× 58 0.6× 11 0.2× 22 681
Ana Alvarez-Requejo Spain 8 32 0.2× 90 0.8× 25 0.3× 17 0.2× 247 3.6× 13 576
Alex Dodoo Ghana 10 24 0.2× 27 0.2× 91 0.9× 17 0.2× 131 1.9× 14 406
Prasad Thota India 12 33 0.2× 42 0.4× 118 1.2× 33 0.4× 114 1.7× 32 336

Countries citing papers authored by Alana Arnold

Since Specialization
Citations

This map shows the geographic impact of Alana Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alana Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alana Arnold more than expected).

Fields of papers citing papers by Alana Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alana Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alana Arnold. The network helps show where Alana Arnold may publish in the future.

Co-authorship network of co-authors of Alana Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of Alana Arnold. A scholar is included among the top collaborators of Alana Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alana Arnold. Alana Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Pereira, Luis M., Gregory S. Matte, Peter Lutz, Alana Arnold, & Al Patterson. (2017). Production Standard and Stability of Compounded Del Nido Cardioplegia Solution. Hospital Pharmacy. 52(11). 766–773. 4 indexed citations
2.
Connor, Jean A., et al.. (2016). Implementing a Distraction-Free Practice With the Red Zone Medication Safety Initiative. Dimensions of Critical Care Nursing. 35(3). 116–124. 12 indexed citations
3.
Obeng, Esther A., et al.. (2014). Pediatric Heparin-Induced Thrombocytopenia: Prevalence, Thrombotic Risk, and Application of the 4Ts Scoring System. The Journal of Pediatrics. 166(1). 144–150.e1. 37 indexed citations
4.
Moniz, Thomas, et al.. (2014). Sterile product compounding using an i.v. compounding workflow management system at a pediatric hospital. American Journal of Health-System Pharmacy. 71(15). 1311–1317. 28 indexed citations
5.
Demirjian, Alicia, Yaron Finkelstein, Alejandro A. Nava‐Ocampo, et al.. (2013). A Randomized Controlled Trial of a Vancomycin Loading Dose in Children. The Pediatric Infectious Disease Journal. 32(11). 1217–1223. 19 indexed citations
6.
Cami, Aurel, Shannon Manzi, Alana Arnold, & Ben Y. Reis. (2013). Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions. PLoS ONE. 8(4). e61468–e61468. 62 indexed citations
7.
Cami, Aurel, Alana Arnold, Shannon Manzi, & Ben Y. Reis. (2011). Predicting Adverse Drug Events Using Pharmacological Network Models. Science Translational Medicine. 3(114). 114ra127–114ra127. 96 indexed citations
8.
Fox, LeAnne M., et al.. (2006). Neonatal Babesiosis. The Pediatric Infectious Disease Journal. 25(2). 169–173. 56 indexed citations
9.
Bolon, Maureen, Alana Arnold, Henry A. Feldman, et al.. (2005). Evaluating Vancomycin Use at a Pediatric Hospital: New Approaches and Insights. Infection Control and Hospital Epidemiology. 26(1). 47–55. 23 indexed citations
10.
Bolon, Maureen, Alana Arnold, Henry A. Feldman, Donald A. Goldmann, & Sharon B. Wright. (2005). An Antibiotic Order Form Intervention Does Not Improve or Reduce Vancomycin Use. The Pediatric Infectious Disease Journal. 24(12). 1053–1058. 17 indexed citations
11.
Turvey, Stuart E., Beth Cronin, Alana Arnold, & Anahita F. Dioun. (2004). Antibiotic desensitization for the allergic patient: 5 years of experience and practice. Annals of Allergy Asthma & Immunology. 92(4). 426–432. 45 indexed citations
12.
Hansen, Anne, Peter Forbes, Alana Arnold, & Edward J. OʼRourke. (2003). Once-daily Gentamicin Dosing for the Preterm and Term Newborn: Proposal for a Simple Regimen that Achieves Target Levels. Journal of Perinatology. 23(8). 635–639. 34 indexed citations
13.
Arnold, Alana, et al.. (2001). Practice Guidelines for Lipid-Based Amphotericin B in Stem Cell Transplant Recipients. Annals of Pharmacotherapy. 35(2). 206–216. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alphienes Stanley Xavier Breakdown of academic impact, for papers by George Adjei Breakdown of academic impact, for papers by Lionel Van Holle Breakdown of academic impact, for papers by Fatai A. Fehintola Breakdown of academic impact, for papers by Maxwell Chirehwa Breakdown of academic impact, for papers by Patricia Lizak Breakdown of academic impact, for papers by Eliford Ngaimisi Breakdown of academic impact, for papers by Ana Alvarez-Requejo Breakdown of academic impact, for papers by Alex Dodoo Breakdown of academic impact, for papers by Prasad Thota
Rankless by CCL
2026